Second Pfizer/BioNTech bivalent COVID-19 booster vaccine approved by UK medicines regulator

This adapted COVID-19 vaccine targets both the original virus and the Omicron BA.4 and BA.5 sub-variants

Approval has today [Nov. 9] been granted by the Medicines and Healthcare products Regulatory Agency (MHRA) for a Pfizer/BioNTech ‘bivalent’ Covid vaccine that targets both the Original strain of SARS-CoV-2 and the Omicron BA.4 and BA.5 sub-variants.

The updated booster vaccine is the second bivalent vaccine from Pfizer/BioNTech to receive MHRA approval, after it was found to meet the UK regulator’s standards of safety, quality and effectiveness.

The vaccine has been approved for use as a booster dose in individuals aged 12 years and above.

https://www.gov.uk/government/news/second-pfizerbiontech-bivalent-covid-19-booster-vaccine-approved-by-uk-medicines-regulator

Moderator's note: the prior, original version of the Pfizer bivalent COVID vaccine approved in the UK targeted earlier Omicron variants before BA.4 and BA.5.

https://uk.news.yahoo.com/pfizer-biontech-covid-19-booster-114312142.html